Christopher Benecchi insider trades

Open-market stock purchases and sales by Christopher Benecchi, Chief Operating Officer at Sage Therapeutics, Inc, from SEC Form 4 filings since Oct 1, 2021.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • SAGE Sage Therapeutics, Inc: other filings, last Jul 31, 2025

Get free alerts when Christopher Benecchi files a new trade →